Article

Brief Communication: Impact of Pretreatment HIV-1 Drug Resistance on Virologic Outcomes in Ugandan Patients infected with Non-B HIV-1 Subtypes

2026-04-19

Abstract excerpt

<title>Abstract</title> <p>Background Pretreatment HIV-1 drug resistance (PDR), including minority variants, may compromise antiretroviral therapy (ART) outcomes but remains underexplored in non-B HIV-1 subtypes. Methods This longitudinal study enrolled 106 ART-naïve Ugandan adults (2018–2020) to assess the impact of majority (≥ 20%) and minority (< 20%) pretreatment HIV-1 drug resistance mutations on virologic...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c25202c2-de8a-5fd7-9ceb-6e2e243e5fef
DOI: 10.21203/rs.3.rs-9308576/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Brief Communication: Impact of Pretreatment HIV-1 Drug Resistance on Virologic Outcomes in Ugandan Patients infected with Non-B HIV-1 SubtypesDOI 10.21203/rs.3.rs-9308576/v1Read

Prevalence of HIV drug resistance, its correlates and common mutations among people living with HIV failing on ART in northern Uganda. A cross-sectional studySemantic proximity Read

Prevalence of HIV drug resistance, its correlates and common mutations among people living with HIV failing on ART in northern Uganda: A cross-sectional study.Semantic proximity Read

Next-generation sequencing (NGS) reveals low-abundance HIV-1 drug resistance mutations among patients experiencing virological failure at the time of therapy switching in UgandaSemantic proximity Read

Population dynamics of HIV drug resistance during treatment scale-up in Uganda: a population-based longitudinal studySemantic proximity Read

High Levels of Acquired HIV Drug Resistance Following Virological Nonsuppression in HIV-Infected Women from a High-Risk Cohort in Uganda.Semantic proximity Read

Comparison of HIV drug resistance profiles across HIV-1 subtypes A and D for patients receiving a tenofovir-based and zidovudine-based first line regimens in Uganda.Semantic proximity Read

Do HIV-1 non-B subtypes differentially impact resistance mutations and clinical disease progression in treated populations? Evidence from a systematic review.Semantic proximity Read

Prevalence of Pre-antiretroviral-Treatment Drug Resistance by Gender, Age, and Other Factors in HIV-Infected Individuals Initiating Therapy in Kenya, 2013-2014.Semantic proximity Read

Pretreatment HIV drug resistance among adults initiating ART in Namibia.Semantic proximity Read

High frequency of HIV-1 drug resistance among individuals with persistent low-level viremia during first-line antiretroviral therapy in Uganda.Semantic proximity Read

HIV-1 Drug Resistance Trends in the Era of Modern Antiretrovirals: 2018–2024Semantic proximity Read

High levels of HIV drug resistance among adults failing second-line antiretroviral therapy in NamibiaSemantic proximity Read